The current vaccine against the new Corona variant Omicron is not as effective as before. This new variant found in South Africa has also raised new concerns in the financial markets.
A Reuters report on Tuesday (November 30th) quoted Stephen Bansel, CEO of Modern, as saying.
Stephen Bansel, CEO of Modern, says it takes longer to wait for data. I have talked to many scientists. They told me that the new type would not be good for us. Decreasing the effectiveness of the vaccine will increase the number of hospital admissions and prolong the epidemic.
Bansel said it could take months to develop a vaccine against Omicron. A new type of coronavirus, Omicron, has created a new threat to the world.
Concerns are growing about this. Experts say that this form of coronavirus has caused at least 32 mutations. Its scientific name is B.1.1.529.
It can spread very quickly and easily in human body. As a result, the vaccine is expected to be less effective. This is why scientists are most concerned about Omicron.
The World Health Organization first received confirmation of the Omicron variant in South Africa on November 24. It then spread to other parts of the world, including the Netherlands, Denmark, and Australia. As a result, many countries have imposed travel bans, including border closures.